Location History:
- Ecublens, CH (2020)
- Prilly, CH (2016 - 2024)
Company Filing History:
15 out of 39 
3 out of 526 
1 out of 6,274 
Years Active: 2016-2025
Title: Innovations in Cardiac Valve Technology: The Contributions of Fabien Lombardi
Introduction: Fabien Lombardi, an inventive mind located in Prilly, Switzerland, has made significant contributions to the field of cardiac medical devices with a total of 19 patents to his name. Known for his innovative approach, Lombardi has focused particularly on transcatheter stent-valves, which have transformed the way cardiac valve replacements are performed.
Latest Patents: Among his latest patents is a method and apparatus for compressing/loading stent-valves. This apparatus features a two-stage compression system designed to facilitate the implantation of stent-valves. The first compressor stage includes a hollow channel with a tapered interior surface that compresses the stent-valve during longitudinal advancement. The second compressor stage utilizes a crimper which allows for additional compression without the need for longitudinal movement. This innovative approach significantly enhances the deliverability of stent-valves for transcatheter implantation. Additionally, the patented stent-valve is designed to be compressible for delivery and is capable of expanding to an operative state once implanted. Key features include a stent, a series of leaflets forming a prosthetic valve, an inner and outer skirt, as well as a paravalve seal that reacts to blood or its components, providing a secure seal against surrounding tissue.
Career Highlights: Fabien Lombardi has been instrumental in advancing cardiac medical technology through his work with prominent companies such as Symetis SA and Boston Scientific Corporation. His dedication to innovation in this space showcases his commitment to improving patient outcomes and leveraging technology to aid medical procedures.
Collaborations: Throughout his career, Lombardi has collaborated with esteemed professionals in the field, including Jean-Luc Hefti and Youssef Biadillah. Their teamwork has further contributed to the development of cutting-edge solutions in cardiac valve replacements.
Conclusion: Fabien Lombardi stands out as a pivotal figure in the realm of cardiac innovations. With a growing portfolio of patents and a career built on collaboration and excellence, he continues to push the boundaries of what is possible in cardiac valve technology. His inventions not only reflect his expertise but also hold the potential to significantly enhance cardiac treatment methodologies in the future.